Valeant Pharmaceuticals International (NYSE:VRX)

CAPS Rating: 3 out of 5

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

Recs

0
Player Avatar Retire20150 (57.06) Submitted: 9/23/2011 10:26:10 PM : Outperform Start Price: $38.33 VRX Score: +11.22

Generics are en vogue.

Featured Broker Partners


Advertisement